Literature DB >> 14292265

BIOPHARMACEUTICAL INVESTIGATION OF NALIDIXIC ACID IN MAN.

W E MOORE, G A PORTMANN, H STANDER, E W MCCHESNEY.   

Abstract

Entities:  

Keywords:  ABSORPTION; ANTI-INFECTIVE AGENTS; EXCRETION; METABOLISM; MODELS, THEORETICAL; NALIDIXIC ACID; NAPHTHYRIDINES; URINE

Mesh：

Substances：

Year:  1965        PMID： 14292265     DOI： 10.1002/jps.2600540109

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  3 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Infection-responsive drug delivery from urinary biomaterials controlled by a novel kinetic and thermodynamic approach.

Authors:  Nicola J Irwin; Colin P McCoy; David S Jones; Sean P Gorman
Journal:  Pharm Res       Date:  2012-11-15       Impact factor: 4.200

3.  Nalidixic acid kinetics in renal insufficiency.

Authors:  G Cuisinaud; N Ferry; N Pozet; P Y Zech; J Sassard
Journal:  Br J Clin Pharmacol       Date:  1982-10       Impact factor: 4.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.